Table of Contents
ISRN Psychiatry
Volume 2014 (2014), Article ID 652750, 8 pages
http://dx.doi.org/10.1155/2014/652750
Clinical Study

Metabotropic Glutamate Receptor 5 Negative Modulation in Phase I Clinical Trial: Potential Impact of Circadian Rhythm on the Neuropsychiatric Adverse Reactions—Do Hallucinations Matter?

1Rob Giel Research Centre, Department of Psychiatry, University Medical Centre Groningen (UMCG), Hanzeplein 1, 9713 GZ Groningen, The Netherlands
2Department of Epidemiology (Medical Statistics), University Medical Centre Groningen (UMCG), Hanzeplein 1, 9713 GZ Groningen, The Netherlands

Received 30 October 2013; Accepted 21 January 2014; Published 4 March 2014

Academic Editors: C. Bonetto and A. Squassina

Copyright © 2014 Khalid Abou Farha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. J. Gregory, E. N. Dong, J. Meiler, and P. J. Conn, “Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential,” Neuropharmacology, vol. 60, no. 1, pp. 66–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Brown, S. Mustafa, M. A. Ayoub et al., “mGlu5 receptor functional interactions and addiction,” Front Pharmacology, vol. 7, no. 3, p. 84, 2012. View at Publisher · View at Google Scholar
  3. U. C. Campbell, K. Lalwani, L. Hernandez, G. G. Kinney, P. J. Conn, and L. J. Bristow, “The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats,” Psychopharmacology, vol. 175, no. 3, pp. 310–318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Durand, L. Carniglia, C. Caruso et al., “Metabotropic glutamate receptors in peripheral tissues: implications for toxicology,” in Anxiety Disorders, Mental and Behavioural Disorders and Diseases of the Nervous System, V. Kalinin, Ed., pp. 97–120, Slavka Krautzeka, Croatia, 2011. View at Google Scholar
  5. American Psychiatric association, Diagnostic and Statistical Manual of Mental Disorders, APA, Washington, DC, USA, 4t edition, 1990.
  6. M. Manford and F. Andermann, “Complex visual hallucinations. Clinical and neurobiological insights,” Brain, vol. 121, no. 10, pp. 1819–1840, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Barnes and A. S. David, “Visual hallucinations in Parkinson's disease: a review and phenomenological survey,” Journal of Neurology Neurosurgery and Psychiatry, vol. 70, no. 6, pp. 727–733, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Hakami, N. C. Jones, E. A. Tolmacheva et al., “NMDA receptor hypofunction leads to generalized and persistent aberrant γ oscillations independent of hyperlocomotion and the state of consciousness,” PLoS ONE, vol. 4, no. 8, Article ID e6755, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Sukumaran, R. R. Almon, D. C. DuBois, and W. J. Jusko, “Circadian rhythms in gene expression: relationship to physiology, disease, drug disposition and drug action,” Advanced Drug Delivery Reviews, vol. 62, no. 9-10, pp. 904–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Erkekoglu and T. Bayder, “Chronopharmacokinetics of drugs in toxicological aspects: a short review for pharmacy practitioners,” Joint Regional Planning Panel, vol. 1, no. 1, pp. 3–9, 2012. View at Google Scholar
  11. S. L. Miksys and R. F. Tyndale, “Drug-metabolizing cytochrome P450s in the brain,” Journal of Psychiatry and Neuroscience, vol. 27, no. 6, pp. 406–415, 2002. View at Google Scholar · View at Scopus
  12. C. Ghosh, N. Marchi, N. K. Desai et al., “Cellular localization and functional significance of CYP3A4 in the human epileptic brain,” Epilepsia, vol. 52, no. 3, pp. 562–571, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. S. Ferguson and R. F. Tyndale, “Cytochrome P450 enzymes in the brain: emerging evidence of biological significance,” Trends in Pharmacological Sciences, vol. 32, no. 12, pp. 708–714, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-K. J. Zhang, R. L. Yeager, and C. D. Klaassen, “Circadian expression profiles of drug-processing genes and transcription factors in mouse liver,” Drug Metabolism and Disposition, vol. 37, no. 1, pp. 106–115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Lemmer and G. Nold, “Circadian changes in estimated hepatic blood flow in healthy subjects,” British Journal of Clinical Pharmacology, vol. 32, no. 5, pp. 627–629, 1991. View at Google Scholar · View at Scopus
  16. Y. Touitou, C. Touitou, and A. Bogdan, “Differeneces between young and elderly subjects in seasonal and circadian variations of total plasma proteins and blood volume as reflected by hemoglobin, hematocrit, and erythrocyte counts,” Clinical Chemistry, vol. 32, no. 5, pp. 801–804, 1986. View at Google Scholar · View at Scopus
  17. H. Ito, K. Takahashi, J. Hatazawa, S.-G. Kim, and I. Kanno, “Changes in human regional cerebral blood flow and cerebral blood volume during visual stimulation measured by positron emission tomography,” Journal of Cerebral Blood Flow and Metabolism, vol. 21, no. 5, pp. 608–612, 2001. View at Google Scholar · View at Scopus
  18. D. A. Conroy, A. J. Spielman, and R. Q. Scott, “Daily rhythm of cerebral blood flow velocity,” Journal of Circadian Rhythms, vol. 3, no. 3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Mody and J. Maguire, “The reciprocal regulation of stress hormones and GABAA receptors,” Frontiers in Cellular Neuroscience, vol. 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. B. K. Hoffpauir and E. L. Gleason, “Modulation of synaptic function in retinal amacrine cells,” Integrative and Comparative Biology, vol. 45, no. 4, pp. 658–664, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Bradbury, D. R. Giracello, D. F. Chapman et al., “Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic-pituitary-adrenal axis activity: Interaction with serotonergic systems,” Neuropharmacology, vol. 44, no. 5, pp. 562–572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. A. N. Vgontzas, E. O. Bixler, H.-M. Lin et al., “Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 8, pp. 3787–3794, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. K. C. Marsden, J. B. Beattie, J. Friedenthal, and R. C. Carroll, “NMDA receptor activation potentiates inhibitory transmission through GABA receptor-associated protein-dependent exocytosis of GABAA receptors,” Journal of Neuroscience, vol. 27, no. 52, pp. 14326–14337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Cleva and M. F. Olive, “Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders,” Molecules, vol. 16, no. 3, pp. 2097–2106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-H. Chen, P.-F. Liao, and M.-H. Chan, “MGluR5 positive modulators both potentiate activation and restore inhibition in NMDA receptors by PKC dependent pathway,” Journal of Biomedical Science, vol. 18, no. 1, article 19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Barnes and A. S. David, “Visual hallucinations in Parkinson's disease: a review and phenomenological survey,” Journal of Neurology Neurosurgery and Psychiatry, vol. 70, no. 6, pp. 727–733, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. T. E. Kim, H. J. Kim, J. H. Park et al., “Cognitive dysfunction with complex visual hallucinations due to focal nonconvulsive status epilepticus: a neuropsychological study and SISCOM,” Seizure, vol. 21, no. 8, pp. 658–660, 2012. View at Publisher · View at Google Scholar